Industries > Pharma > Drug Discovery Outsourcing Market Forecast 2017-2027

Drug Discovery Outsourcing Market Forecast 2017-2027

Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies

PUBLISHED: 13 October 2017
PAGES: 225
PRODUCT CODE: PHA0246

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

Drug Discovery Outsourcing – our new study reveals trends, R&D progress, and predicted revenues
Where is the Drug Discovery Outsourcing market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 225-page report provides 150 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Drug Discovery Outsourcing market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there forecasts for 4 Drug Discovery Submarkets,

Global Drug Discovery Outsourcing Submarkets
• Chemistry Services
• Biology Services
• Lead Optimisation
• Lead Identification and Screening

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 13 leading national markets:
• The US
• Germany
• The UK
• Italy
• Spain
• France
• Russia
• Japan
• South Korea
• China
• India
• Brazil
• Mexico

Drug Discovery Outsourcing Market Forecast 2017-2027

The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, India, Brazil and Mexico in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Drug Discovery Outsourcing will surpass $21bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Drug Discovery Outsourcing Market report helps you
In summary, our 225-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the Drug Discovery Outsourcing market, with forecasts for 4 submarkets, each forecasted at a global level – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 13 key national markets – See forecasts for the Drug Discovery Outsourcing market in the US, Mexico, Brazil, Germany, France, the UK, Italy, Spain, Russia, China, India, Japan, and South Korea
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
– including company profiles for 10 of the major companies involved in the Drug Discovery Outsourcing market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing market and leading companies. You will find data, trends and predictions.

Get our report today Drug Discovery Outsourcing Market Forecast 2017-2027: Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Drug Discovery Outsourcing Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Drug Discovery Outsourcing Market Forecast 2017-2027


Latest Pharma news

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

READ

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

READ

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

READ

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

READ

Categories

Category